Leef Brands (LEEEF) Depreciation & Amortization (CF) (2025 - 2026)
Leef Brands (LEEEF) posted Depreciation & Amortization (CF) of $568141.0 for Q1 2026, up 6.15% sequentially from $535237.0 in Q1 2025, and up 6.15% YoY from $535237.0 in Q1 2025.
Leef Brands (LEEEF) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends
Leef Brands has reported Depreciation & Amortization (CF) for 2 years, with the latest figure at $568141.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 6.15% year-over-year to $568141.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (changed N/A YoY) and the FY2025 annual result came in at $2.3 million, up 21.44% from the prior year.
- Depreciation & Amortization (CF) grew to $568141.0 in Q1 2026 per LEEEF's latest filing, from $535237.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $568141.0 in Q1 2026 and troughed at $535237.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Leef Brands | 58.70 Mn | 53.75 Mn | 2.41 Mn | 656,858.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 656,858.00 |
| Jun 30, 2026 | 656,858.00 |
| Mar 31, 2026 | 568,141.00 |
| Mar 31, 2026 | 568,141.00 |
| Mar 31, 2025 | 535,237.00 |
| Mar 31, 2025 | 535,237.00 |